Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Neonatal Consultations: Persistent Diaper Rash and Langerhans Cell Histiocytosis

Description

The presentation discusses two neonatal cases involving persistent diaper rash and Langerhans Cell Histiocytosis (LCH). The first case features a six-week-old infant with scaly papules and plaques, initially considered a common diaper rash, but further examination revealed a more complex condition. The baby exhibited signs of LCH, confirmed through biopsy results showing eosinophilic cells and CD1A positivity, along with imaging showing lesions impacting the orbital area. Treatment began with chemotherapy and prednisone. The second case was a three-week-old baby with recurrent scrotal ulcerations diagnosed with neonatal lupus due to positive maternal antibodies (SSB) and subtle skin lesions. The discussion highlighted the importance of differential diagnosis in cases of diaper rash, noting conditions like allergic dermatitis, infections, and more serious conditions like LCH and lupus. Management strategies for both conditions were outlined, emphasizing early diagnosis and the need for multidisciplinary approaches, including oncology consultations for LCH and potential cardiac evaluations for neonatal lupus. The cases underscore the complexity of dermatological presentations in neonates and the critical role of timely intervention.

View more

Conclusions

  • Persistent diaper rash in infants may indicate underlying conditions such as Langerhans cell histiocytosis (LCH) or neonatal lupus erythematosus.
  • A thorough evaluation, including possible biopsy and imaging, is essential for diagnosing persistent diaper rash cases.
  • LCH is characterized by clonal malignancies of myeloid cells and can present with diverse skin lesions and associated organ involvement.
  • Early recognition and treatment of LCH with protocols like vinblastine and prednisone can lead to significant improvements.
  • Neonatal lupus can arise from maternal antibodies and may involve various organ systems, contributing to skin and systemic manifestations.
  • Preventive measures, including maternal treatment during pregnancy, can mitigate risks associated with neonatal lupus.
  • Children with cutaneous manifestations of LCH require careful monitoring and may benefit from targeted therapies based on their mutation profile.
  • Allen CE, et al. N Engl J Med. 2018 Aug 30;379(9):856-868.
  • Han, D.; et al. J. Pers. Med. 2022, 12, 1024.
  • Kwon H, et al. Ann Dermatol. 2009 Aug;21(3):277-280.
  • Fraitag S, et al. Dermatopathology (Basel). 2021 Aug 17;8(3):390-417.
  • Ong, S et al. Cutis. 2023 September;112(3):131,135-136.
  • Diaz-Frias, Jose. StatPearls Publishing; 2024 Jan.
  • Liszewska A, Woźniacka A. Neonatal lupus erythematosus - prevention is better than cure. Postepy Dermatol Alergol. 2022 Dec;39(6):1021-1026.
  • Moretti D, Cimaz R, Vannucci G, Marino A, De Martino M, Greco A. Cutaneous neonatal lupus: a case report and review of the literature. International journal of dermatology. 2014;53(12):1508-1512.
  • Buyon JP, Clancy RM, Friedman DM. Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside. Nature clinical practice Rheumatology. 2009;5(3):139-148.
  • Li Y-q, Wang Q, Luo Y, Zhao Y. Neonatal lupus erythematosus: a review of 123 cases in China. International Journal of Rheumatic Diseases.
  • Rivera TL, Izmirly PM, Birnbaum BK, et al. Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus. Annals of the rheumatic diseases. 2009;68(6):828-835.
  • Li L, Dong GF, Han FZ, Cui Y, Shi YZ, Zhang X. Neonatal lupus erythematosus: a report of 7 cases and review of 87 cases of China. Zhonghua er ke za zhi = Chinese journal of pediatrics. 2011;49(2):146-150.
  • Izmirly PM, Llanos C, Lee LA, Askanase A, Kim MY, Buyon JP. Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block. Arthritis and rheumatism. 2010;62(4):1153-1157.
  • Chang YS, Yang YH, Chiang BL. Neonatal Behcet's disease without maternal history. Clinical rheumatology. 2011;30(12):1641-1645.
  • Izmirly PM, Costedoat-Chalumeau N, Pisoni CN, et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation. 2012;126(1):76-82.
  • Martinez-Sanchez N, Robles-Marhuenda A, Alvarez-Doforno R, et al. The effect of a triple therapy on maternal anti-Ro/SS-A levels associated to fetal cardiac manifestations. Autoimmunity reviews. 2015;14(5):423-428.